Document Detail


3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity.
MedLine Citation:
PMID:  8410999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A series of (3R*,4R*)-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists with varying substituents on the nitrogen were evaluated for their effect on food consumption in obese Zucker rats. Opioid affinity (mu, kappa, and delta for selected compounds) and opioid antagonist activity (mu and kappa) were characterized and compared to effects on food consumption. No compounds with high selectivity for either mu or kappa receptors were discovered. However, compounds in the series had exceptional potency as opioid antagonists and in reducing food consumption in the obese Zucker rat. In contrast, a few compounds with high potency as opioid antagonists had much weaker potency for inhibiting food consumption. (3R,4R)-3,4-Dimethyl-1-[(3S)-3- hydroxy-3-cyclohexyl-propyl]-4-(3-hydroxyphenyl)piperidine (11,LY255582) emerged as having the best activity profile, both in reducing food consumption and as an opioid antagonist. Compound 11 is a highly potent mu, kappa-, and delta-opioid antagonist with possible clinical utility as an appetite suppressant for weight loss.
Authors:
C H Mitch; J D Leander; L G Mendelsohn; W N Shaw; D T Wong; B E Cantrell; B G Johnson; J K Reel; J D Snoddy; A E Takemori
Related Documents :
9246559 - How constant is an individual's route of heroin administration? data from treatment and...
23364019 - Liking compared with wanting for high- and low-calorie foods in anorexia nervosa: aberr...
16274849 - Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrain...
11225639 - Intracerebroventricularly administered corticotropin-releasing factor inhibits food int...
17562389 - Gabaergic mechanisms of the lateral parabrachial nucleus on sodium appetite.
15845619 - Central relaxin-3 administration causes hyperphagia in male wistar rats.
22188599 - Availability of, access to and consumption of fruits and vegetables in a peri-urban are...
11518559 - Food biotechnology: dietitians' resource needs as determined by selected canadian key i...
18677819 - International conference on harmonisation; guidance on q4b evaluation and recommendatio...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  36     ISSN:  0022-2623     ISO Abbreviation:  J. Med. Chem.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1993-11-09     Completed Date:  1993-11-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2842-50     Citation Subset:  IM    
Affiliation:
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesia
Animals
Appetite Depressants / chemistry,  metabolism,  pharmacology*
Cyclohexanes / chemistry,  metabolism,  pharmacology*
Diuresis / drug effects
Eating / drug effects
Endorphins / antagonists & inhibitors*
Guinea Pigs
Male
Mice
Molecular Structure
Piperidines / chemistry,  metabolism,  pharmacology*
Rats
Rats, Sprague-Dawley
Rats, Zucker
Receptors, Opioid, delta / antagonists & inhibitors,  physiology
Receptors, Opioid, kappa / antagonists & inhibitors,  physiology
Receptors, Opioid, mu / antagonists & inhibitors,  physiology
Structure-Activity Relationship
Chemical
Reg. No./Substance:
0/Appetite Depressants; 0/Cyclohexanes; 0/Endorphins; 0/Piperidines; 0/Receptors, Opioid, delta; 0/Receptors, Opioid, kappa; 0/Receptors, Opioid, mu; 120938-72-9/LY 243670

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for...
Next Document:  Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicoc...